BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 20085962)

  • 1. A review of pharmacologic options for previously untreated chronic lymphocytic leukemia.
    Wilhelm K; Yang D
    J Oncol Pharm Pract; 2011 Jun; 17(2):91-103. PubMed ID: 20085962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in the diagnosis and treatment of chronic lymphocytic leukemia.
    Abbott BL
    Clin Adv Hematol Oncol; 2004 Jul; 2(7):448-54. PubMed ID: 16163221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment options for newly diagnosed patients with chronic lymphocytic leukemia.
    Erba HP
    Curr Hematol Rep; 2004 Jan; 3(1):47-53. PubMed ID: 14695850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rituximab plus fludarabine and cyclophosphamide or other agents in chronic lymphocytic leukemia.
    Robak T; Lech-Maranda E; Robak P
    Expert Rev Anticancer Ther; 2010 Oct; 10(10):1529-43. PubMed ID: 20942624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of chronic lymphocytic leukemia.
    Faderl SJ; Keating MJ
    Curr Hematol Rep; 2005 Jan; 4(1):31-8. PubMed ID: 15610657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemoimmunotherapy of chronic lymphocytic leukemia.
    Tam CS; Keating MJ
    Best Pract Res Clin Haematol; 2007 Sep; 20(3):479-98. PubMed ID: 17707835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pentostatin (Nipent) and chlorambucil with granulocyte-macrophage colony-stimulating factor support for patients with previously untreated, treated, and fludarabine-refractory B-cell chronic lymphocytic leukemia.
    Waselenko JK; Grever MR; Beer M; Lucas MA; Byrd JC
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):44-51. PubMed ID: 10877052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in the diagnosis and treatment of chronic lymphocytic leukemia.
    Abbott BL
    Hematol Oncol; 2005 Mar; 23(1):34-40. PubMed ID: 16149106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controversies in the front-line management of chronic lymphocytic leukemia.
    Nabhan C; Shanafelt TD; Kay NE
    Leuk Res; 2008 May; 32(5):679-88. PubMed ID: 18191201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of advanced chronic lymphocytic leukemia.
    Cao TM; Coutre SE
    Curr Hematol Rep; 2003 Jan; 2(1):65-72. PubMed ID: 12901156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Etiology and management of tumor lysis syndrome in patients with chronic lymphocytic leukemia.
    Cheson BD
    Clin Adv Hematol Oncol; 2009 Apr; 7(4):263-71. PubMed ID: 19521331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic lymphocytic leukemia in the elderly population.
    Rai KR
    Clin Geriatr Med; 1997 May; 13(2):245-9. PubMed ID: 9115449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bendamustine for the treatment of chronic lymphocytic leukemia and rituximab-refractory, indolent B-cell non-Hodgkin lymphoma.
    Dennie TW; Kolesar JM
    Clin Ther; 2009; 31 Pt 2():2290-311. PubMed ID: 20110042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of immunochemotherapy in the treatment of chronic lymphocytic leukemia.
    Del Poeta G; Ilaria Del Principe M; Buccisano F; Maurillo L; Niscola P; Venditti A; Amadori S
    Expert Rev Anticancer Ther; 2006 Dec; 6(12):1787-800. PubMed ID: 17181492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chlorambucil in indolent chronic lymphocytic leukemia. French Cooperative Group on Chronic Lymphocytic Leukemia.
    Dighiero G; Maloum K; Desablens B; Cazin B; Navarro M; Leblay R; Leporrier M; Jaubert J; Lepeu G; Dreyfus B; Binet JL; Travade P
    N Engl J Med; 1998 May; 338(21):1506-14. PubMed ID: 9593789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical roundtable monograph. New alternatives in CLL therapy: managing adverse events.
    Chanan-Khan A; Kipps T; Stilgenbauer S
    Clin Adv Hematol Oncol; 2010 Aug; 8(8):suppl 1-15. PubMed ID: 21192630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibody therapy of chronic lymphocytic leukemia.
    Mavromatis B; Cheson BD
    J Clin Oncol; 2003 May; 21(9):1874-81. PubMed ID: 12721266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic lymphocytic leukaemia: current first-line therapy.
    Carney DA; Mulligan SP
    Intern Med J; 2009 Jan; 39(1):44-8. PubMed ID: 19290981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of chronic lymphocytic leukemia.
    Han T; Rai KR
    Hematol Oncol Clin North Am; 1990 Apr; 4(2):431-45. PubMed ID: 2182600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purine analogue-based chemotherapy regimens for patients with previously untreated B-chronic lymphocytic leukemia.
    Kay NE
    Semin Hematol; 2006 Apr; 43(2 Suppl 2):S50-4. PubMed ID: 16549115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.